UiPath (NYSE:PATH – Free Report) had its price objective increased by Mizuho from $22.00 to $25.00 in a report released on Thursday, Benzinga reports. Mizuho currently has a neutral rating on the healthcare company’s stock.
Other research analysts also recently issued reports about the company. Canaccord Genuity Group lifted their price target on UiPath from $27.00 to $30.00 and gave the stock a buy rating in a research report on Friday. BMO Capital Markets boosted their price objective on UiPath from $24.00 to $28.00 and gave the company a market perform rating in a research report on Thursday. Royal Bank of Canada boosted their price objective on UiPath from $27.00 to $29.00 and gave the company a sector perform rating in a research report on Thursday. Needham & Company LLC boosted their price objective on UiPath from $25.00 to $30.00 and gave the company a buy rating in a research report on Thursday. Finally, Morgan Stanley boosted their price objective on UiPath from $17.00 to $25.00 and gave the company an equal weight rating in a research report on Thursday. Nine research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of Hold and a consensus target price of $27.13.
Check Out Our Latest Report on UiPath
UiPath Stock Up 1.4 %
Insiders Place Their Bets
In other UiPath news, Director Rich Wong sold 200,000 shares of the business’s stock in a transaction on Monday, January 8th. The stock was sold at an average price of $23.12, for a total value of $4,624,000.00. Following the transaction, the director now owns 429,418 shares of the company’s stock, valued at $9,928,144.16. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, Director Rich Wong sold 200,000 shares of the company’s stock in a transaction on Monday, January 8th. The stock was sold at an average price of $23.12, for a total transaction of $4,624,000.00. Following the transaction, the director now owns 429,418 shares of the company’s stock, valued at $9,928,144.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Ashim Gupta sold 70,000 shares of the company’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $23.02, for a total value of $1,611,400.00. Following the transaction, the chief financial officer now directly owns 788,148 shares in the company, valued at approximately $18,143,166.96. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 411,000 shares of company stock valued at $9,418,670. 31.03% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On UiPath
Several large investors have recently made changes to their positions in the company. Mark Sheptoff Financial Planning LLC acquired a new position in UiPath in the fourth quarter valued at about $25,000. HighMark Wealth Management LLC acquired a new position in UiPath in the fourth quarter valued at about $27,000. Tyler Stone Wealth Management acquired a new position in UiPath in the second quarter valued at about $28,000. Cypress Capital Management LLC WY acquired a new position in UiPath in the fourth quarter valued at about $29,000. Finally, Fifth Third Bancorp increased its holdings in shares of UiPath by 2,005.3% in the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock worth $34,000 after acquiring an additional 1,905 shares in the last quarter. Institutional investors and hedge funds own 59.04% of the company’s stock.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
- Five stocks we like better than UiPath
- The How and Why of Investing in Gold Stocks
- Walmart: Here’s Your Chance to Get in Cheaper in 2024
- What Does Downgrade Mean in Investing?
- Insider Selling of Amazon Spikes in Q1, but it’s Not Time to Sell
- Transportation Stocks Investing
- 2 Deep Value, High Yield Stocks With a Double-Digit Upside
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.